ENTRADA THERAPEUTICS, INC. Company Profile
ENTRADA THERAPEUTICS, INC. as SEC EDGAR records it: incorporation, addresses, industry, fiscal year end, filer category and former names.
- Incorporated: Value 2016-09-22.
- Current registered country: Value Delaware, United States.
- Country of operation (business address): Value United States.
- Business address: Value ONE DESIGN CENTER PLACE, SUITE 17-500, BOSTON, Massachusetts, 02210, United States.
| Measure | Value |
|---|---|
| Incorporated | 2016-09-22 “The Company was incorporated in Delaware on September 22, 2016, and its principal offices are located in Boston, Massachusetts.” 10-K filed 2026-02-26 |
| Current registered country | Delaware, United States SEC EDGAR state of incorporation DE |
| Country of operation (business address) | United States |
| Business address | ONE DESIGN CENTER PLACE, SUITE 17-500, BOSTON, Massachusetts, 02210, United States |
| Mailing address | ONE DESIGN CENTER PLACE, SUITE 17-500, BOSTON, Massachusetts, 02210, United States |
| Industry (SIC) | 2834 Pharmaceutical Preparations |
| Fiscal year end | 12-31 |
| Filer category | Accelerated filer<br>Smaller reporting company<br>Emerging growth company |
| Listed stock (Section 12(b)) | Common Stock, par value $0.0001 per share · TRDA · The Nasdaq Global Market 10-Q filed 2026-08-05 cover |
| Shell company | No 10-Q filed 2026-08-05 cover |
| Smaller reporting company | Yes 10-Q filed 2026-08-05 cover |
| Emerging growth company | Yes 10-Q filed 2026-08-05 cover |
| Current in its reporting | Yes 10-Q filed 2026-08-05 cover |
| Well-known seasoned issuer | No 10-K filed 2026-02-26 cover |
| Voluntary filer | No 10-K filed 2026-02-26 cover |
| Former names | CycloPorters, Inc. (2016-11-10 to 2016-11-10) |
| First EDGAR filing | 2016-11-10 (D) |
| SEC CIK | 1689375 |
| EIN | 813983399 |
| Phone | 857-305-1825 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |